iShares S&P Global Healthcare Sector Index Fund  (IXJ) Trade Now »     Rate IXJ  -  Discuss IXJ  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

IXJ Analysis & Videos »


IXJ: Bull or Bear?

Beyond Active ETFs: Build Your Own IXJ

73%

+19.17% in 323 days Beyond Active ETFs: Build Your Own <> Index Universe reported last week that Grail Partners has requested SEC approval to launch two new exchange-traded funds (ETFs) which are actively managed and do not track an underlying index. The Grail American Beacon Large Cap Value ETF and the Grail American Beacon International Equity ETF would not have any restrictions on trading, but Grail expects to provide more details on target turnover rates for the funds once the managers and investment strategy is in place. As an alternative investing strategy, why not create your ow... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  01/18/09

Comment

A New Global Healthcare Composite Index IXJ

73%

+0.51% in 5 days (closed on 01/18/09) A New Global Healthcare Composite Index <> The accompanying table [click to enlarge] presents the top five rated companies with market caps of at least $100M from each of the eight new ETF Innovators healthcare indexes, including a database exceeding 500 companies worldwide. The Healthcare Composite Index is a dynamic, semi-active index with quarterly rebalancing which consists of the 40 top-rated companies on an equal weight basis from each of the eight global healthcare indexes listed below and represents an alternative strategy to existing health composite ETF... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  01/13/09

Comment

Healthcare ETFs Outpace the Market IXJ

73%

-4.24% in 72 days (closed on 01/13/09) Healthcare ETFs Outpace the Market <> The accompanying table presents an analysis and statistics for the 28 healthcare ETFs listed at the Yahoo! Finance ETF Center. As a group, the healthcare ETFs outpaced the overall market in the past year by more than 10%, posting an average loss of 26.5% compared to a loss of 37.4% for the S&P 500 SPDR ETF (SPY). The best performing healthcare ETF was the Biotech HOLDRs (BBH), thanks to a buyout bid for top holding Genetech (DNA) and solid earnings results this year for the number two position, Amgen (AMGN). The top three... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/01/08

Comment

Global AnimalBiz Posts Loss, Outpaces Healthcare ETFs IXJ

73%

+2.93% in 15 days (closed on 11/01/08) Global AnimalBiz Posts Loss, Outpaces Healthcare ETFs <> <> The ETFI Global AnimalBiz Index includes a total of 35 companies with market caps between $100 million to $10 billion U.S. Dollars, with a semi-active rating system which is rebalanced each quarter to choose the top 25 rated companies as active components. The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (Intervet), Novartis, Pfizer, Merck + Sanofi-Aventis joint venture (Merial), Wyeth (Fort Dodge), and Eli Lilly (Elanco). These comp... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  10/17/08

Comment

A Bayer Buyout by Pfizer? IXJ

50%

-2.53% in 453 days A Bayer Buyout by Pfizer? <> <> Shares of German drug maker and chemical concern Bayer ( Germany: BAY ) were boosted by about 3% in early trading today on word that Pfizer (PFE) may be interested in acquiring the company for its prescription drug business and pipeline. Shares of Bayer are currently valued at a market cap of about $59 billion US Dollars, which is less than half of the $129 billion market value of Pfizer. Such a deal would likely involve a break-up of Bayer, since the Company derives 31% of its sales from pharmaceuticals, 13% from consumer hea... Continue reading »

By  Mike Havrilla   (-9.11%  risk: conservative)  09/09/08

Comment

A Global AnimalBiz Index IXJ

50%

+0.76% in 5 days (closed on 09/09/08) <> The accompanying tables present an overview of the market cap-weighted Global AnimalBiz Index, which includes 32 companies with market caps between $100 million to $10 billion US Dollars. The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (Intervet), Novartis, Pfizer, Merck + Sanofi-Aventis joint venture ( Merial ), Wyeth (Fort Dodge), and Eli Lilly (Elanco). These companies are excluded to make the index more leveraged to animal care as this segment typically represents only about 5% of their sales.... Continue reading »

By  Mike Havrilla   (-9.11%  risk: conservative)  09/04/08

Comment

Global Healthcare IXJ ...

Continue reading »

9 %

-2.26% in 605 days Health care is the sector to be in for many years to come.This etf provides exposure to top global pharma majors at one go.It also has many Bufett picks. From Yahoo finance top holdings TOP 10 HOLDINGS ( 49.88% OF TOTAL ASSETS)   <spacer type="block" height="1" width="1"> </spacer> <> <> <> <> <> <> <>

Company

By  Thomas George   (-4.57%  risk: moderate)  04/10/08

Comment

People Bullish on IXJ

Mike Havrilla Principal 73% 10 mos ago

Mike Havrilla Associate 50% about 1 year ago

Thomas George Sr. Associate  9 % about 1 year ago

People Bearish on IXJ

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.